363 related articles for article (PubMed ID: 33562819)
21. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
22. CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action.
Dawidowicz AL; Olszowy-Tomczyk M; Typek R
Fitoterapia; 2021 Jul; 152():104915. PubMed ID: 33964342
[TBL] [Abstract][Full Text] [Related]
23. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification.
Peschel W; Politi M
Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837
[TBL] [Abstract][Full Text] [Related]
24. The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling.
Lah TT; Majc B; Novak M; Sušnik A; Breznik B; Porčnik A; Bošnjak R; Sadikov A; Malavolta M; Halilčević S; Mlakar J; Zomer R
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497400
[TBL] [Abstract][Full Text] [Related]
25. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
Marcu JP; Christian RT; Lau D; Zielinski AJ; Horowitz MP; Lee J; Pakdel A; Allison J; Limbad C; Moore DH; Yount GL; Desprez PY; McAllister SD
Mol Cancer Ther; 2010 Jan; 9(1):180-9. PubMed ID: 20053780
[TBL] [Abstract][Full Text] [Related]
26. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
[TBL] [Abstract][Full Text] [Related]
27. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
De Petrocellis L; Vellani V; Schiano-Moriello A; Marini P; Magherini PC; Orlando P; Di Marzo V
J Pharmacol Exp Ther; 2008 Jun; 325(3):1007-15. PubMed ID: 18354058
[TBL] [Abstract][Full Text] [Related]
28. An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma.
Colvin EK; Hudson AL; Anderson LL; Kumar RP; McGregor IS; Howell VM; Arnold JC
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954477
[TBL] [Abstract][Full Text] [Related]
29. The Origin and Biomedical Relevance of Cannabigerol.
Jastrząb A; Jarocka-Karpowicz I; Skrzydlewska E
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887277
[TBL] [Abstract][Full Text] [Related]
30. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
[TBL] [Abstract][Full Text] [Related]
31. Cannabidiol and Cannabigerol, Nonpsychotropic Cannabinoids, as Analgesics that Effectively Manage Bone Fracture Pain and Promote Healing in Mice.
Khajuria DK; Karuppagounder V; Nowak I; Sepulveda DE; Lewis GS; Norbury CC; Raup-Konsavage WM; Vrana KE; Kamal F; Elbarbary RA
J Bone Miner Res; 2023 Nov; 38(11):1560-1576. PubMed ID: 37597163
[TBL] [Abstract][Full Text] [Related]
32. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
Guzmán M; Duarte MJ; Blázquez C; Ravina J; Rosa MC; Galve-Roperh I; Sánchez C; Velasco G; González-Feria L
Br J Cancer; 2006 Jul; 95(2):197-203. PubMed ID: 16804518
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
34. Raman-Based Differentiation of Hemp, Cannabidiol-Rich Hemp, and Cannabis.
Sanchez L; Baltensperger D; Kurouski D
Anal Chem; 2020 Jun; 92(11):7733-7737. PubMed ID: 32401504
[TBL] [Abstract][Full Text] [Related]
35. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.
Borrelli F; Pagano E; Romano B; Panzera S; Maiello F; Coppola D; De Petrocellis L; Buono L; Orlando P; Izzo AA
Carcinogenesis; 2014 Dec; 35(12):2787-97. PubMed ID: 25269802
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation.
Vacek J; Vostalova J; Papouskova B; Skarupova D; Kos M; Kabelac M; Storch J
Free Radic Biol Med; 2021 Feb; 164():258-270. PubMed ID: 33453360
[TBL] [Abstract][Full Text] [Related]
37. Cannabigerol and cannabichromene in
Zagožen M; Čerenak A; Kreft S
Acta Pharm; 2021 Sep; 71(3):355-364. PubMed ID: 36654096
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.
Cerretani D; Collodel G; Brizzi A; Fiaschi AI; Menchiari A; Moretti E; Moltoni L; Micheli L
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752303
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.
Brierley DI; Harman JR; Giallourou N; Leishman E; Roashan AE; Mellows BAD; Bradshaw HB; Swann JR; Patel K; Whalley BJ; Williams CM
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):844-859. PubMed ID: 31035309
[TBL] [Abstract][Full Text] [Related]
40. Phytocannabinoids as novel therapeutic agents in CNS disorders.
Hill AJ; Williams CM; Whalley BJ; Stephens GJ
Pharmacol Ther; 2012 Jan; 133(1):79-97. PubMed ID: 21924288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
